Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target from $158 to $141.
JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $230 to $200.
Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its ...
Zoetis (NYSE:ZTS) affirms FY2025 Adj EPS guidance from $6.30-$6.40 to $6.30-$6.40 vs $6.35 analyst estimate. Lowers FY2025 sale...
Zoetis (NYSE:ZTS) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.62 by 4.81 per...
Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovet...
Adhishthana.com analysis reveals why Zoetis stock may remain sluggish through June 2026, as weak triads weigh on its final phase.
